B2DB — Who said what, where, and when

Jan E Hansen

Sanofi

Jan E Hansen is listed as Sanofi. Jan is scheduled to speak at ISPOR Europe 2026 on 10 November 2026.

Compiled from published conference agendas; not yet confirmed by Jan. Is this you? Claim this profile.

About

Dr. Jan Hansen is Global Head of Health Economics and Value Assessment (HEVA), which is a function in the Global Market Access organization in Sanofi's Specialty Care business. In this role, Jan oversees global health economics and outcomes research (HEOR) strategy development and tactical project execution. Her team’s work leads to impactful dissemination and application of HEOR across global stakeholders and health care systems. Prior to joining Sanofi, Jan had an impressive career spanning over three decades in life sciences. Jan has held distinguished leadership positions at Genentech and Allergan, where she demonstrated her talent for building and guiding high-performing HEOR and access teams. Her expertise in integrating health economics and HTA considerations into development strategies has consistently led to successful product positioning and enhanced patient reach. As a past President of ISPOR and active contributor to prestigious organizations like the National Pharmaceutica

Upcoming

ISPOR Europe 2026 8 November 2026 – 11 November 2026